![Andrew R. Clark](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew R. Clark
Direktor/Vorstandsmitglied bei Respira Therapeutics, Inc.
Profil
Andrew R.
Clark currently works at SolAeroMed, Inc., as Director and Respira Therapeutics, Inc., as Director.
Aktive Positionen von Andrew R. Clark
Unternehmen | Position | Beginn |
---|---|---|
Respira Therapeutics, Inc.
![]() Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | Direktor/Vorstandsmitglied | 09.02.2015 |
SolAeroMed, Inc.
![]() SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
SolAeroMed, Inc.
![]() SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Health Technology |
Respira Therapeutics, Inc.
![]() Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | Health Technology |